Back to User profile » Dr Gabriel Tremblay

Papers published by Dr Gabriel Tremblay:

Original Research

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea

Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J

ClinicoEconomics and Outcomes Research 2016, 8:485-493

Published Date: 19 September 2016

Methodology

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Tremblay G, Livings C, Crowe L, Kapetanakis V, Briggs A

ClinicoEconomics and Outcomes Research 2016, 8:323-333

Published Date: 30 June 2016

Original Research

Matching-adjusted indirect treatment comparison in patients with radioiodine-refractory differentiated thyroid cancer

Tremblay G, Holbrook T, Milligan G, Pelletier CL, Rietschel P

Comparative Effectiveness Research 2016, 6:13-21

Published Date: 20 April 2016

Original Research

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer

Fordham BA, Kerr C, de Freitas HM, Lloyd AJ, Johnston K, Pelletier CL, Tremblay G, Forsythe A, McIver B, Cohen EEW

Patient Preference and Adherence 2015, 9:1561-1572

Published Date: 3 November 2015